Research programme: glucagon-like peptide-2 analogues - Theratechnologies

Drug Profile

Research programme: glucagon-like peptide-2 analogues - Theratechnologies

Alternative Names: TH 0312

Latest Information Update: 19 Mar 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Theratechnologies
  • Class Peptides
  • Mechanism of Action Glucagon-like peptide 2 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Inflammatory bowel diseases

Most Recent Events

  • 16 Sep 2004 A preclinical study has been added to the Inflammatory Bowel Disorders pharmacodynamics section
  • 15 Jun 2004 Preclinical trials in Inflammatory bowel disease disease in Canada (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top